CN106620887A - 一种药物球囊的生产方法 - Google Patents
一种药物球囊的生产方法 Download PDFInfo
- Publication number
- CN106620887A CN106620887A CN201610971410.XA CN201610971410A CN106620887A CN 106620887 A CN106620887 A CN 106620887A CN 201610971410 A CN201610971410 A CN 201610971410A CN 106620887 A CN106620887 A CN 106620887A
- Authority
- CN
- China
- Prior art keywords
- production method
- medicinal
- drug solution
- balloon
- taxol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 188
- 229940079593 drug Drugs 0.000 title claims abstract description 124
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 41
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical class O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims abstract description 87
- 238000005507 spraying Methods 0.000 claims abstract description 51
- 239000013078 crystal Substances 0.000 claims abstract description 43
- 239000002904 solvent Substances 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 35
- 230000008569 process Effects 0.000 claims abstract description 24
- 238000005516 engineering process Methods 0.000 claims abstract description 20
- 229930012538 Paclitaxel Natural products 0.000 claims description 80
- 229960001592 paclitaxel Drugs 0.000 claims description 79
- 239000000243 solution Substances 0.000 claims description 74
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 239000003960 organic solvent Substances 0.000 claims description 24
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 19
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 15
- 239000008213 purified water Substances 0.000 claims description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 12
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 5
- 239000004202 carbamide Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 229920001800 Shellac Polymers 0.000 claims description 4
- 239000003684 drug solvent Substances 0.000 claims description 4
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims description 4
- 239000004208 shellac Substances 0.000 claims description 4
- 229940113147 shellac Drugs 0.000 claims description 4
- 235000013874 shellac Nutrition 0.000 claims description 4
- 229950008882 polysorbate Drugs 0.000 claims description 3
- 229920000136 polysorbate Polymers 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 235000016408 Podocarpus macrophyllus Nutrition 0.000 claims description 2
- 244000162450 Taxus cuspidata Species 0.000 claims description 2
- 235000009065 Taxus cuspidata Nutrition 0.000 claims description 2
- 238000013329 compounding Methods 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- -1 iodine Amine Chemical class 0.000 claims description 2
- 239000003186 pharmaceutical solution Substances 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- DCTZJRUXIXPDJP-UHFFFAOYSA-N trihexyl 2-hydroxy-4-oxoheptane-1,2,3-tricarboxylate Chemical compound CCCCCCOC(=O)CC(O)(C(=O)OCCCCCC)C(C(=O)CCC)C(=O)OCCCCCC DCTZJRUXIXPDJP-UHFFFAOYSA-N 0.000 claims description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 claims 2
- 238000000576 coating method Methods 0.000 abstract description 29
- 239000011248 coating agent Substances 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 239000000758 substrate Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 238000002425 crystallisation Methods 0.000 description 9
- 230000008025 crystallization Effects 0.000 description 9
- 239000007921 spray Substances 0.000 description 8
- 238000012545 processing Methods 0.000 description 7
- DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 229960002603 iopromide Drugs 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000012795 verification Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000001878 scanning electron micrograph Methods 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000001000 micrograph Methods 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 238000005411 Van der Waals force Methods 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 230000010148 water-pollination Effects 0.000 description 2
- UKAPYNPLXZAGQD-UHFFFAOYSA-M 2-carboxyphenolate;1-hexadecylpyridin-1-ium Chemical compound OC1=CC=CC=C1C([O-])=O.CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 UKAPYNPLXZAGQD-UHFFFAOYSA-M 0.000 description 1
- WUPLWFRHWSPKJA-UHFFFAOYSA-N 2-hydroxy-4-oxoheptane-1,2,3-tricarboxylic acid Chemical compound CCCC(=O)C(C(O)=O)C(O)(C(O)=O)CC(O)=O WUPLWFRHWSPKJA-UHFFFAOYSA-N 0.000 description 1
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000004804 Butyryltrihexylcitrate Substances 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000050510 Cunninghamia lanceolata Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229940008309 acetone / ethanol Drugs 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 201000006828 endometrial hyperplasia Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 150000004579 taxol derivatives Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- GWVUTNGDMGTPFE-UHFFFAOYSA-N trihexyl 2-butanoyloxypropane-1,2,3-tricarboxylate Chemical compound CCCCCCOC(=O)CC(C(=O)OCCCCCC)(OC(=O)CCC)CC(=O)OCCCCCC GWVUTNGDMGTPFE-UHFFFAOYSA-N 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1027—Making of balloon catheters
- A61M25/1029—Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A61L2300/608—Coatings having two or more layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
- A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/02—Methods for coating medical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2420/00—Materials or methods for coatings medical devices
- A61L2420/08—Coatings comprising two or more layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1027—Making of balloon catheters
- A61M25/1029—Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
- A61M2025/1031—Surface processing of balloon members, e.g. coating or deposition; Mounting additional parts onto the balloon member's surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Child & Adolescent Psychology (AREA)
- Manufacturing & Machinery (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610971410.XA CN106620887B (zh) | 2016-11-03 | 2016-11-03 | 一种药物球囊的生产方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610971410.XA CN106620887B (zh) | 2016-11-03 | 2016-11-03 | 一种药物球囊的生产方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106620887A true CN106620887A (zh) | 2017-05-10 |
CN106620887B CN106620887B (zh) | 2019-12-03 |
Family
ID=58820991
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610971410.XA Active CN106620887B (zh) | 2016-11-03 | 2016-11-03 | 一种药物球囊的生产方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106620887B (zh) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107088259A (zh) * | 2017-06-09 | 2017-08-25 | 上海心至医疗科技有限公司 | 一种药物球囊及其制备方法 |
CN107362439A (zh) * | 2017-08-14 | 2017-11-21 | 乐普(北京)医疗器械股份有限公司 | 一种药物涂层球囊导管的制备方法、制备得到的药物涂层球囊导管及其应用 |
CN107376030A (zh) * | 2017-08-09 | 2017-11-24 | 乐普(北京)医疗器械股份有限公司 | 一种药物球囊的制备方法、制备得到的药物球囊及其应用 |
CN107670163A (zh) * | 2017-11-02 | 2018-02-09 | 乐普(北京)医疗器械股份有限公司 | 一种药物球囊扩张导管及其制备方法和应用 |
CN108295361A (zh) * | 2018-02-23 | 2018-07-20 | 北京东方金荣超声电器有限公司 | 一种药物球囊涂药设备 |
CN109954198A (zh) * | 2017-12-25 | 2019-07-02 | 先健科技(深圳)有限公司 | 药物球囊及其制备方法 |
CN111001044A (zh) * | 2019-12-30 | 2020-04-14 | 上海申淇医疗科技有限公司 | 一种药物球囊、其涂覆药物的制备及药物球囊的制备方法 |
CN112023124A (zh) * | 2019-06-03 | 2020-12-04 | 上海微创医疗器械(集团)有限公司 | 结晶型涂层及其制备方法和应用 |
WO2020258834A1 (zh) * | 2019-06-27 | 2020-12-30 | 山东瑞安泰医疗技术有限公司 | 一种药物洗脱球囊导管及其制备方法 |
CN112546414A (zh) * | 2021-02-22 | 2021-03-26 | 上海微创医疗器械(集团)有限公司 | 载药医疗器械及其制备方法 |
CN114558232A (zh) * | 2021-11-15 | 2022-05-31 | 浙江巴泰医疗科技有限公司 | 一种用于大尺寸球囊的药物涂层及其制备方法 |
CN115581848A (zh) * | 2022-10-17 | 2023-01-10 | 上海申淇医疗科技有限公司 | 一种药物球囊的制备方法 |
CN116585602A (zh) * | 2023-07-18 | 2023-08-15 | 上海威高医疗技术发展有限公司 | 一种提高球囊表面药物利用率的方法及制备的球囊 |
CN117065186A (zh) * | 2023-09-01 | 2023-11-17 | 贝朗医疗(苏州)有限公司 | 一种药物球囊的涂药方法和系统 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010086863A2 (en) * | 2009-02-02 | 2010-08-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Crystalline drug-containing coatings |
EP2676687A1 (en) * | 2008-06-25 | 2013-12-25 | Boston Scientific Scimed, Inc. | Medical devices containing therapeutic agents |
WO2014011805A1 (en) * | 2012-07-10 | 2014-01-16 | Bayer Pharma Aktiengesellschaft | Catheter with drug coating |
CN104056341A (zh) * | 2014-06-24 | 2014-09-24 | 深圳市金瑞凯利生物科技有限公司 | 药物球囊及其制备方法 |
CN104353132A (zh) * | 2014-11-21 | 2015-02-18 | 浙江归创医疗器械有限公司 | 一种植入或介入医疗器械上药物涂层的涂覆工艺 |
CN104511084A (zh) * | 2014-12-30 | 2015-04-15 | 深圳市信立泰生物医疗工程有限公司 | 一种球囊导管 |
EP2453938B1 (en) * | 2009-07-17 | 2015-08-19 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
CN104922735A (zh) * | 2015-06-24 | 2015-09-23 | 颜玉强 | 一种药物球囊的制备方法 |
-
2016
- 2016-11-03 CN CN201610971410.XA patent/CN106620887B/zh active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2676687A1 (en) * | 2008-06-25 | 2013-12-25 | Boston Scientific Scimed, Inc. | Medical devices containing therapeutic agents |
WO2010086863A2 (en) * | 2009-02-02 | 2010-08-05 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Crystalline drug-containing coatings |
EP2453938B1 (en) * | 2009-07-17 | 2015-08-19 | Boston Scientific Scimed, Inc. | Nucleation of drug delivery balloons to provide improved crystal size and density |
WO2014011805A1 (en) * | 2012-07-10 | 2014-01-16 | Bayer Pharma Aktiengesellschaft | Catheter with drug coating |
CN104056341A (zh) * | 2014-06-24 | 2014-09-24 | 深圳市金瑞凯利生物科技有限公司 | 药物球囊及其制备方法 |
CN104353132A (zh) * | 2014-11-21 | 2015-02-18 | 浙江归创医疗器械有限公司 | 一种植入或介入医疗器械上药物涂层的涂覆工艺 |
CN104511084A (zh) * | 2014-12-30 | 2015-04-15 | 深圳市信立泰生物医疗工程有限公司 | 一种球囊导管 |
CN104922735A (zh) * | 2015-06-24 | 2015-09-23 | 颜玉强 | 一种药物球囊的制备方法 |
Non-Patent Citations (1)
Title |
---|
于文国等: "《生化分离技术》", 31 March 2006, 化学工业出版社 * |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107088259A (zh) * | 2017-06-09 | 2017-08-25 | 上海心至医疗科技有限公司 | 一种药物球囊及其制备方法 |
CN107376030A (zh) * | 2017-08-09 | 2017-11-24 | 乐普(北京)医疗器械股份有限公司 | 一种药物球囊的制备方法、制备得到的药物球囊及其应用 |
CN107376030B (zh) * | 2017-08-09 | 2020-08-07 | 乐普(北京)医疗器械股份有限公司 | 一种药物球囊的制备方法、制备得到的药物球囊及其应用 |
CN107362439A (zh) * | 2017-08-14 | 2017-11-21 | 乐普(北京)医疗器械股份有限公司 | 一种药物涂层球囊导管的制备方法、制备得到的药物涂层球囊导管及其应用 |
CN107670163A (zh) * | 2017-11-02 | 2018-02-09 | 乐普(北京)医疗器械股份有限公司 | 一种药物球囊扩张导管及其制备方法和应用 |
CN109954198A (zh) * | 2017-12-25 | 2019-07-02 | 先健科技(深圳)有限公司 | 药物球囊及其制备方法 |
CN109954198B (zh) * | 2017-12-25 | 2021-10-12 | 先健科技(深圳)有限公司 | 药物球囊及其制备方法 |
CN108295361B (zh) * | 2018-02-23 | 2023-10-03 | 北京东方金荣超声电器有限公司 | 一种药物球囊涂药设备 |
CN108295361A (zh) * | 2018-02-23 | 2018-07-20 | 北京东方金荣超声电器有限公司 | 一种药物球囊涂药设备 |
CN112023124A (zh) * | 2019-06-03 | 2020-12-04 | 上海微创医疗器械(集团)有限公司 | 结晶型涂层及其制备方法和应用 |
CN112023124B (zh) * | 2019-06-03 | 2022-11-29 | 上海微创医疗器械(集团)有限公司 | 结晶型涂层及其制备方法和应用 |
WO2020258834A1 (zh) * | 2019-06-27 | 2020-12-30 | 山东瑞安泰医疗技术有限公司 | 一种药物洗脱球囊导管及其制备方法 |
CN111001044A (zh) * | 2019-12-30 | 2020-04-14 | 上海申淇医疗科技有限公司 | 一种药物球囊、其涂覆药物的制备及药物球囊的制备方法 |
CN112546414A (zh) * | 2021-02-22 | 2021-03-26 | 上海微创医疗器械(集团)有限公司 | 载药医疗器械及其制备方法 |
CN112546414B (zh) * | 2021-02-22 | 2021-06-08 | 上海微创医疗器械(集团)有限公司 | 载药医疗器械及其制备方法 |
CN114558232A (zh) * | 2021-11-15 | 2022-05-31 | 浙江巴泰医疗科技有限公司 | 一种用于大尺寸球囊的药物涂层及其制备方法 |
CN115581848A (zh) * | 2022-10-17 | 2023-01-10 | 上海申淇医疗科技有限公司 | 一种药物球囊的制备方法 |
CN115581848B (zh) * | 2022-10-17 | 2024-05-24 | 上海申淇医疗科技有限公司 | 一种药物球囊的制备方法 |
CN116585602A (zh) * | 2023-07-18 | 2023-08-15 | 上海威高医疗技术发展有限公司 | 一种提高球囊表面药物利用率的方法及制备的球囊 |
CN116585602B (zh) * | 2023-07-18 | 2023-10-03 | 上海威高医疗技术发展有限公司 | 一种提高球囊表面药物利用率的方法及制备的球囊 |
CN117065186A (zh) * | 2023-09-01 | 2023-11-17 | 贝朗医疗(苏州)有限公司 | 一种药物球囊的涂药方法和系统 |
CN117065186B (zh) * | 2023-09-01 | 2024-04-16 | 贝朗医疗(苏州)有限公司 | 一种药物球囊的涂药方法和系统 |
Also Published As
Publication number | Publication date |
---|---|
CN106620887B (zh) | 2019-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106620887B (zh) | 一种药物球囊的生产方法 | |
CN106237395B (zh) | 一种药物涂层球囊及其制备方法 | |
CN110292701A (zh) | 一种药物洗脱球囊导管及其制备方法 | |
US20160331870A1 (en) | Drug Coated Balloon Catheter | |
CN106334220B (zh) | 医疗器械上药物涂层的涂覆工艺 | |
CN104841060B (zh) | 一种超声控释药物洗脱球囊导管及其制备方法 | |
CN104324421A (zh) | 治疗用球囊扩张导管药物涂层的制备方法 | |
CN106075703A (zh) | 载药球囊及其载药球囊的制造方法 | |
Sansone et al. | Physical characteristics and aerosol performance of naringin dry powders for pulmonary delivery prepared by spray-drying | |
CN104922735B (zh) | 一种药物球囊的制备方法 | |
CN104353132A (zh) | 一种植入或介入医疗器械上药物涂层的涂覆工艺 | |
CN106267377A (zh) | 药物涂层球囊导管 | |
CN103566415B (zh) | 一种双面涂层的人体血管植入物及其制作方法 | |
CN109985280A (zh) | 药物球囊及其制备方法 | |
CN206604008U (zh) | 一种药物涂层球囊扩张导管 | |
CN107376030A (zh) | 一种药物球囊的制备方法、制备得到的药物球囊及其应用 | |
CN114259606A (zh) | 一种药物球囊导管及药物球囊的表面处理方法 | |
CN110251738B (zh) | 药物球囊的制备方法及药物球囊 | |
CN115382026B (zh) | 含药物涂层材料及其制备、含药物涂层医疗器械及其制备 | |
CN107754022A (zh) | 一种药物涂层及其制备方法 | |
CN107496998A (zh) | 外周药物洗脱支架及其制备和应用 | |
CN111588914A (zh) | 介入或植入医疗器械的药物涂层及其制备方法 | |
CN204246659U (zh) | 一种药物缓释球囊导管 | |
CN106237330A (zh) | 用于动脉血管病变扩张载药球囊的复配药物及载药球囊 | |
WO2019019043A1 (zh) | 一种表面液化药物涂层球囊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 201203, room 8, building 200, 601 Newton Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Patentee after: Shanghai Shenqi Medical Technology Co.,Ltd. Address before: 201203, room 8, building 200, 601 Newton Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Patentee before: SHANGHAI SHENQI MEDICAL TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 201203, room 8, building 200, 601 Newton Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Patentee after: SHANGHAI SHENQI MEDICAL TECHNOLOGY CO.,LTD. Address before: 201203, room 8, building 200, 601 Newton Road, Zhangjiang hi tech park, Shanghai, Pudong New Area Patentee before: Shanghai Shenqi Medical Technology Co.,Ltd. |